The Cardinal Edge
Volume 1 Issue 1

Article 22

2021

Microbial Influence on Alzheimer's Disease
Ashley N. Hamby
University of Louisville, ashley.hamby@louisville.edu

Follow this and additional works at: https://ir.library.louisville.edu/tce
Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, Medical
Microbiology Commons, Medical Pathology Commons, and the Virus Diseases Commons

Recommended Citation
Hamby, Ashley N. (2021) "Microbial Influence on Alzheimer's Disease," The Cardinal Edge: Vol. 1 , Article
22.
DOI: 10.18297/tce/vol1/iss1/22
Available at: https://ir.library.louisville.edu/tce/vol1/iss1/22

This Literature Review is brought to you for free and open access by ThinkIR: The University of Louisville's
Institutional Repository. It has been accepted for inclusion in The Cardinal Edge by an authorized editor of ThinkIR:
The University of Louisville's Institutional Repository. For more information, please contact thinkir@louisville.edu.

Microbial Influence on Alzheimer's Disease
Erratum
A prior version of the article was initially published. This is the most recent and up-to-date version of the
article.

This literature review is available in The Cardinal Edge: https://ir.library.louisville.edu/tce/vol1/iss1/22

LITERATURE REVIEW

Microbial Influence on Alzheimer’s Disease
Ashley Hamby1
1

The University of Louisville, Louisville, KY, USA

BACKGROUND
Alzheimer’s Disease (AD) is a progressive
neurodegenerative disease generally characterized by loss
of memory, disorientation, and mood/behavioral changes.
Advanced cases of AD may also include difficulty
performing basic motor skills such as speaking and
walking. There are two types of AD that lead to these
devastating symptoms. Familial AD has an early onset
and is linked to deterministic mutations in amyloid
precursor protein (APP), presenilin-1 (PSEN1), and
presenilin-2 (PSEN2) genes [16]. On the other hand,
sporadic AD has a late onset and is associated to both the
apolipoprotein E (APOE) gene and environmental causes.
Examples of environmental factors include exposure to
pollution/asbestos, diet, tobacco usage, and exercise [26].
Prolonged neuroinflammation leads to the formation and
prolonged presence of beta-amyloid plaques and
neurofibrillary
tangles
(comprised
of
hyperphosphorylated tau proteins) that prevent normal
neurological functioning; the two formations are key
criteria necessary for official diagnosis of both familial
and sporadic forms of the disease [24,41].
AD currently has no means of therapeutic intervention
despite extensive molecular research, emphasizing the
vast complexity of the disease. As a result, scientists
expanded their prospects towards other potential
therapeutic targets, taking large interest in the human
flora. Though this flora is largely populated by bacteria,
other organisms like archaea, protozoa, fungi, and viruses
are also present in several systems of the body. This
review article will focus on evidence published by various
researchers that suggests microbial involvement plays a
large role in the development and progression of AD.

Beta-Amyloid Plaques
APP, one of the proteins linked to familial AD, is
responsible for synaptic stability and neuronal protection
[9]. Normally, it is processed by α-secretase and γsecretase to form soluble APPα [9]. Beta amyloid plaques
are formed by accumulation of Aß40 and Aß42 peptides
following aberrant processing of APP by ß- and γsecretases [33]. Aß42 specifically is toxic and susceptible
to aggregation compared to its counterpart, Aß40 [27].
Both frequent pathogen colonization and/or failure to
remove these peptides via exocytosis to form soluble

oligomers following appropriate use can lead to overaccumulation between the neuronal spaces [35]. This
agglomeration leads to the formation of plaques that are
responsible for deteriorating nigh brain tissue through the
interception of cell function. Duplications of the proteincoding APP gene can also result in excessive proliferation
of APP, leading to Aß build-up [9].
Conversely, recent research has proposed that Aß
accumulations display antimicrobial properties, which
supports the idea of plaque formation occurring as a
response to microbial colonization. In a study comparing
Aß activity against twelve microorganisms, Aß was
reported to thwart further microbial growth [43]. These
findings suggest amyloid plaques may be present as a
result of defensive responses against pathogen
colonization. Further research, however, has not yet been
published quantifying healthy versus excessive amounts
of the peptide in question. One of the major hypotheses in
the development of AD suggests Aß protein to be the
causative agent of Alzheimer’s with subsequent
hyperphosphorylation of tau proteins leading to cell loss
and vascular damage [39].

Neurofibrillary Tangles
Tau, the main component of neurofibrillary tangles, is a
protein that normally binds tightly to microtubules within
the brain for functional stabilization [40]. Ordinarily,
phosphorylated and non-phosphorylated tau proteins are
present and regulated by tau kinases and phosphatases
[31]. In the AD-inflicted brain, however, this balance is
disrupted and the regulatory mechanism is impaired,
causing tau to detach from their associated microtubules
and attach to other tau proteins instead. This results in the
hyperphosphorylation of tau proteins that assemble as
tangles [41]. As a consequence, operations like axonal
and dendritic transport are disabled.

Neuroinflammation
Cytokines, which are responsible for the regulation of
immunity and inflammatory responses, have been found
to have significantly elevated concentrations in the AD
brain compared to baseline [44]. For this reason,
increased neuroinflammation, plaques, and tangles are
thought to work in a cyclic manner regarding brain tissue
deterioration. Amyloid plaques, neurofibrillary tangles
and prolonged inflammation lead to tissue damage, but
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neuroinflammation also facilitates further formation of
these debilitating structures [44].

environment, it makes sense that dysbiosis may impede
fine-tuned processes.

Microglial cells are strongly associated with Aß buildup
and enhanced inflammation of brain tissue. Microglial
cells are the major cell type regarding immune responses.
Upon activation, these cells produce cytokines as a
defensive mechanism against pathogen and tissue damage
[51]. Unfortunately, microglial cell activity is highly
associated with neurotoxicity despite its intentionally
helpful function [6]. When repeatedly stimulated,
activation of these cells causes loss of ability to
phagocytose Aß with continued output of cytokines [32],
leading to swift increases in quantity of Aß present.

Gut Microbiota

MICROBES
Microbes, in the eye of the general public, receive a bad
reputation. In reality, the presence and exposure to an
array of microbes can heavily improve the efficiency of
the immune system and help regulate bodily functions
[45]. The human microbiota is constituted by millions of
diverse microbes. These microbes reside in nearly all
regions of the body, but especially large aggregates are
found in the gastrointestinal (GI) tract, skin, oral cavity,
and respiratory tract.

Microbial Gut-Brain Axis
The gut-brain axis (GBA) is a bidirectional
communication system between the central (CNS) and
enteric nervous system (ENS). The CNS encompasses the
brain and spinal cord; the ENS is a division of the
autonomic nervous system that detects and maintains the
physiological conditions of the GI tract and coordinates
intestinal processes like motility, digestion, and barrier
defense [17]. The appropriate development of both
systems is reliant on the optimal balance of intestinal
microbiota, affecting neurotransmitter expression and
turnover rates [10]. In eubiosis, this communication
system relays to the hypothalamic pituitary (HPA) axis,
which acts as the core stress efferent axis and is
responsible for coordination of adaptive responses within
the organism [10]. Moreover, as part of the limbic system,
the HPA axis is involved with memory and emotional
response.
It is known that environmental stressors may activate this
communication system, but recent research has
pinpointed evidence of gut microbiota acting as a
signaling component as well [5]. Study results involving
communication between the vagal nerve and GI tract have
found that gut microbes can indirectly stimulate the ENS
via creation of neurotransmitters, short chain fatty acids,
and/or bacterial metabolites [7]. These communications
may also be introduced through bacteria that induce a
similar effect to host hormones. Naturally, since gut
microbes hold a large role in the regulation of the GI

The GI tract is home to over 1014 microorganisms that aid
in metabolic and homeostatic responses such as enzyme
synthesis, nutrient absorption, and production of shortchain fatty acids [10]. Though the intestinal flora
accumulates during infancy and remains relatively
consistent throughout an individual’s life, patients with
AD showed decreased richness and diversity of microbes
in comparison to non-afflicted individuals of the same age
[49]. Under this principle, it has been established that
obesity has a complex but major role in the residential
phyla of the gut. Multiple studies have compared the
relationship between BMI and present flora to find that
mid-life increases in BMI are correlated with phyla
alteration that ultimately leads to greater risk for AD
development [3,18]. Interestingly, the same studies
discovered that late life increases of BMI protect against
the progression of AD [3,18]. A low-power piloted study
found Actinobacteria to be most abundant in postmortem
AD brain samples, though this must be implemented on a
multi-regional level to better understand the universality
of this finding [52]. Irritable bowel syndrome (IBS) also
has a strong correlation with the development of dementia
secondary to hypothesized gut dysbiosis [12]. Both IBS
and gastroenteritis (a great risk factor for development of
IBS) have shown to be associated with a multitude of
parasitic pathogens and their overgrowth.
There are few GI-involved pathogens specifically
connected to AD. In a study involving AD association
with infectious burden from viruses and bacteria,
Helicobacter pylori was one of five pathogens to
implement higher levels of serum Aß40 and Aß42, which
interferes with synaptic function, compared to those
uninfected [8,19]. It is suggested that H. pylori, which is
typically responsible for gastritis and peptic ulcers
through elevation of pH, also alters cognitive efficiency
through neuroinflammation. Another study exploring the
effects of H. pylori infection found the pathogen to be
responsible for hyperphosphorylation of tau proteins
which are fundamental for neurofibrillary tangles as
mentioned before [50].
Though the causative role of dysbiosis needs further
workup, evaluating the effects of antimicrobial properties
have supported the idea of pathogen-influenced
physiological changes. In a study of transgenic AD mice
raised under germ-free conditions, less cerebral amyloid
depositions were present in comparison to mice exposed
to microbes [21]. Intriguingly, antibiotic treatment is
associated with a decrease in fibril formation and an
increase in cognitive function [46]. It is important to note
that antibiotics vary in terms of ability to cross the blood
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brain barrier (BBB) [34]. Rifampicin, a compound with
penetrative potential, has shown a decrease in Aß toxicity
and aggregation. A study involving mice has also shown
broad-spectrum
antibiotics
to
decrease
tau
phosphorylation [47]. Despite these findings, absence of
microbiota did not equate to complete elimination of
plaque development.

Oral Microbiota
Roughly 700 different microorganisms colonize the
mouth to make up the oral microbiota [25]. While these
microbes are responsible for medical issues such as dental
caries, periodontal disease, and edentulism, they also have
a strong association with AD [36]. Attachment of
microcolonies in the form of biofilms, commonly known
as dental plaques, can result in increased virulence of
pathogens; buildup of dental plaque is commonly
resolved by daily brushing of teeth but may reside if
hygienic practices are not consistent or efficient [28].
Unless gingival ulcers are present, the routine brushing of
teeth poses little to no risk for bacteremia to travel through
the blood stream and colonize the heart and brain [4,22].
Pathogens that lead to periodontitis may colonize the oral
cavity and form toxins that decay the teeth and nearby
issue, which further increase the probability of spread
[23,42]. Porphyromonas gingivalis is considered one the
major infectious agents found in the brain of AD patients
[15]. P. gingivalis may access the brain upon oral
infection through several pathways, including monocytes,
endothelial cells pertaining to the BBB, and/or cranial
nerves [15]. Upon entering the brain, it is suggested that
the bacteria are spread via the same mechanism through
which it invades vascular tissue: it travels through
connected pathways to reach an abundance of neurons
[42]. In patients with active chronic periodontitis (CP)
caused by P. gingivalis, a notable decline in cognition was
reported in comparison to those demented without CP
[23]. P. gingivalis infection can work in conjunction with
genetic factors that pose increased risk of AD
development, such as apolipoprotein E4 (APOE4) and
triggering receptors expressed on myeloid cells
(TREM1/TREM2). With a study involving Apoe-/- mice,
three different bacterial oral infections were induced [38].
Only those infected by P. gingivalis showed infection of
the brain and activation of complement pathways. A
similar study with transgenic mice that overexpressed
mutated human-APP were orally infected by P.
gingivalis. Upon examination of their brains, cognitive
function was deemed impaired and there arose an increase
in deposition of plaques like those in AD patients [42].
Gingipains, the major virulence factor produced by P.
gingivalis, are cysteine proteases made up of lysinegingipain (Kgp), arginine-gingipain A (RgpA) and
arginine-gingipain B (RgpB) [30]. Gingipains suppress
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interleukin-2 (IL-2) secretion, which is an extremely
important humoral immune response to invasion [37].
This ultimately leads an inflammatory cascade to the
brain that modifies the clonal formation of T helper 17
(Th17) cells, resulting in an immune cell population
imbalance that works in favor of P. gingivalis [37]. These
cysteine proteases may induce proteolysis of tau proteins
to which the host attempts to compensate for, increasing
production rates to maintain homeostasis [40]. With
APOE4, the apolipoprotein itself is a large target for
gingipain proteolysis which may result in the generation
of neurotoxic fragments [30]. TREM2, which normally
regulates inflammatory responses, serves as a phagocytic
receptor for bacteria [16]. TREM1, with structural
homology to TREM2, has also been linked with AD as P.
gingivalis has proved to increase expression of the allele
that is already a target for gingipain proteolysis (by Rgp)
and degradation (by Kgp) [16]. These actions have a
correlation with neuroinflammation following infection.
A study evaluating herpes virus simplex 1 (HSV 1) was
also linked to increased risk for the development of AD.
Multiple logistic regressions found that APOE4
frequency was much higher in those affected by both
HSV1 and AD, signifying a strong risk factor when paired
[8]. Though recurrence of HSV1 symptoms lessen with
age, the connection between the virus and APOE4 may
determine the extent of damage. Both the virus and
apolipoproteins bind to heparin sulphate proteoglycans in
cell plasma membranes which affects the number of cells
infected. The mechanism of HSV1 as a vector, however,
must be further investigated.

Respiratory Microbiota
The respiratory tract, with lower components previously
thought to be sterile, actually harbors a large array of
microorganisms that aid in resistance of pathogen
colonization [13,14]. Acutely responsible for communityacquired pneumonia and asthmatic bronchitis, recent
studies have pinpointed Chlamydia pneumoniae infection
as a potential trigger for AD. Mice inoculated with C.
pneumoniae demonstrated Aß42 deposits that steadily
increased in number over the course of 1-3 months [29].
This microorganism has demonstrated elicitation of
extreme inflammatory responses, which are characteristic
in the AD brain [20]. With higher bacterial burden
showed extremely high levels of tissue and cellular
damage within the brains of AD patients. Data also
suggests the load has a positive correlation with the
presence of the APOE4 allele, though the role in
neuropathogenesis is unclear [20].

Mycobiota
Fungal microbial flora makes up less than 1% of the
human flora [48]. Fungi is most typically found either on
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the skin or within the mucosal membranes of the human
body. However, recent examination of brain tissue has
unveiled the presence of fungal DNA and proteins in
patients with AD [2] as well as fungal residues within
neurons [37], all of which were not observed in control
patients. Cerebrospinal fluid (CSF) may tell a lot about
fungal contribution to AD. Within the CSF of those
positive for Alzheimer’s, chitin (the major component of
fungal cell walls) has been identified [11].
Candida albicans is one of the major fungal organisms
found in CSF. Candidemia, caused by C. albicans, proves
the ability of fungi to cross the BBB via mucosal
colonization [51]. Recent studies have shown C. albicans
to increase activation of both interleukins and tumor
necrosis factors, indicating the fungi can cause extensive
neuroinflammation upon seepage into the BBB [51]. The
presence of the fungus within the BBB additionally leads
to enhancement of the development of Aß plaques due to
their antimicrobial properties [43,51]. It is therefore
plausible that formation occurs as a defensive response
against C. albicans. Another cytoplasmic experiment has
found AD brain tissue to have abnormally high amounts
of tau when fungal infection has come into the equation,
though this finding has not been verified through separate
studies [37].

CONCLUSION
Though microbes are not considered to be the sole drivers
in development and progress, there is paramount evidence
supporting the association between dysbiosis and AD.
Further research to understand exact mechanisms of
pathogenesis and roles of individual microorganisms is
imperative if there is any hope for a treatment or cure for
AD. Although fungi has remarkable associations with
AD, significance of the results are limited due to low
quantity of animal studies. This is especially important
considering the conceptual confliction with the amyloid
cascade hypothesis.
It is known that genes like TREM1, TREM2, and
especially APOE4 have a crucial role in the development
of amyloid plaques and neurofibrillary tangles. It would
appear that the presence of the APOE4 allele supports or
promotes pathogenesis of several harmful microbes [20].
These genetic risks impose facilitation of pathogens
through the BBB where they may induce
neuroinflammation and/or development of neurologically
debilitating structures.
Given limited understanding of AD, there is no
guaranteed safety from the disease. However, there are
several preventative measures indicated when
considering aforementioned findings. For example, those
with a higher genetic predisposition to AD yield better
protection when they complete their full antibiotic course

4
prescribed for common infections they may come across
in their lifetime. Whether the antimicrobial treatment is in
place for upper respiratory or oral infections, finishing the
full course of these medications minimizes the risk of
bacterial allocation and/or resistance by limiting the
activation of microglia that leads to inflammation [6].
Proper oral hygiene may also serve as a pertinent step in
prevention of oral-associated infections. Daily removal of
plaques prevents aggregation of P. gingivalis bacteria
responsible for gum disease [28]. Regarding the gut
microbiome, weight maintenance, health-conscious diet
and the consumption of probiotics help prevent the
likelihood of gut dysbiosis by maintaining microbial
diversity [1]. Since genetic changes may not be plausible,
being proactively well-rounded in maintenance of one’s
health is thought to be a supportive factor in keeping
distance from AD.
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